KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardant Health (GH) Gross Margin (2017 - 2026)

Guardant Health's Gross Margin history spans 9 years, with the latest figure at 224.89% for Q4 2025.

  • On a quarterly basis, Gross Margin rose 20057.0% to 224.89% in Q4 2025 year-over-year; TTM through Dec 2025 was 100.0%, a 5143.0% increase, with the full-year FY2025 number at 100.0%, up 4938.0% from a year prior.
  • Gross Margin hit 224.89% in Q4 2025 for Guardant Health, up from 51.97% in the prior quarter.
  • Over the last five years, Gross Margin for GH hit a ceiling of 224.89% in Q4 2025 and a floor of 24.32% in Q4 2024.
  • Historically, Gross Margin has averaged 61.33% across 5 years, with a median of 48.34% in 2023.
  • Biggest five-year swings in Gross Margin: plummeted -16126bps in 2024 and later surged 20057bps in 2025.
  • Tracing GH's Gross Margin over 5 years: stood at 44.87% in 2021, then fell by -20bps to 35.83% in 2022, then surged by 418bps to 185.58% in 2023, then plummeted by -87bps to 24.32% in 2024, then skyrocketed by 825bps to 224.89% in 2025.
  • Business Quant data shows Gross Margin for GH at 224.89% in Q4 2025, 51.97% in Q3 2025, and 48.47% in Q2 2025.